Related Experiment Videos
The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with age
I Irwin1, G A Ricaurte, L E DeLanney
1Institute for Medical Research, San Jose, CA.
Abstract:
The purpose of this study was to determine if the enhanced striatal dopamine depletion induced by MPTP in older mice is due to increasing sensitivity of older nigrostriatal neurons to MPP+ (1-methyl-4-phenylpyridinium ion). MPP+ (the putative toxic metabolite of MPTP) was administered intracerebroventricularly (i.c.v.) to 6- to 8-week-old and 8- to 10-month-old animals. No significant differences in the dopamine-depleting effects of this compound were observed between the two age groups, suggesting that older nigrostriatal neurons are not more sensitive to MPP+. To be certain that increased sensitivity in older animals was not being masked by (1) increased removal of MPP+ from the CNS compartment or (2) enhanced degradation of MPP+, the fate of i.c.v. administered MPP+ was determined in the two age groups using 3H-labeled MPP+ and gas chromatography/mass spectrometry (GC/MS) analysis. No differences were found in the elimination of radioactivity, all of which could be accounted for as MPP+. We conclude that kinetic factors which alter the concentration of MPP+ at its target site, rather than increased sensitivity of older nigrostriatal neurons to MPP+, account for the age-related effects of systemically administered MPTP.
Insights
Older mice do not show increased sensitivity to MPP+, the toxic metabolite of MPTP. Age-related dopamine depletion is instead caused by kinetic factors affecting MPP+ concentration at the target site.
Area of Science:
- Neuroscience
- Toxicology
- Aging Research
Background:
- MPTP (1-methyl-4-phenylpyridinium) induces striatal dopamine depletion, modeling Parkinson's disease.
- Age-related differences in MPTP's neurotoxic effects are observed, but the underlying mechanisms remain unclear.
Purpose of the Study:
- To investigate whether increased sensitivity of nigrostriatal neurons to MPP+ contributes to enhanced MPTP-induced dopamine depletion in aged mice.
- To differentiate between neuronal sensitivity and pharmacokinetic factors in age-related MPTP neurotoxicity.
Main Methods:
- MPP+ (1-methyl-4-phenylpyridinium ion), the toxic metabolite of MPTP, was administered intracerebroventricularly to young and aged mice.
- Dopamine levels in the striatum were measured to assess neurotoxic effects.
- The distribution and elimination of intracerebroventricularly administered 3H-labeled MPP+ were analyzed using gas chromatography/mass spectrometry (GC/MS).
Main Results:
- No significant differences in striatal dopamine depletion were observed between young and aged mice following direct MPP+ administration.
- Pharmacokinetic analysis revealed no age-related differences in MPP+ elimination from the central nervous system.
- All detected radioactivity was confirmed to be MPP+, indicating no enhanced degradation.
Conclusions:
- Older nigrostriatal neurons are not inherently more sensitive to MPP+.
- Age-related differences in MPTP neurotoxicity are primarily attributed to kinetic factors influencing MPP+ concentration at its target site, not increased neuronal vulnerability.